Video

Stacey Cofield, PhD, of NARCOMS

Publish date: October 19, 2015

At ECTRIMS 2015, Dr. Cofield discussed gender differences in attitudes toward marijuana as a treatment for symptoms of MS.

 

References

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel .

Recommended Reading

Do Attitudes Toward Marijuana Differ Between Men and Women With MS?
MDedge Neurology
Long-Term Efficacy of Fingolimod Reinforced by New NEDA-4 Analysis
MDedge Neurology
Minocycline for MS?
MDedge Neurology
Daclizumab Reduces Brain Volume Loss, Compared With Interferon
MDedge Neurology
Cannabinoid Spray Effectively Relieves MS-Related Spasticity
MDedge Neurology
Anti-JCV Antibody Index and L-Selectin Hone PML Risk Stratification During Natalizumab Therapy
MDedge Neurology
Sodium Channel Blockade With Phenytoin Has a Neuroprotective Effect After Acute Optic Neuritis
MDedge Neurology
Daclizumab’s efficacy against MS tempered by adverse events
MDedge Neurology
Ocrelizumab posts first-ever positive outcome data for primary progressive MS
MDedge Neurology
Ocrelizumab decreases relapses, brain lesion development in relapsing-remitting MS
MDedge Neurology

Related Articles